O
Orum Therapeutics Inc
KOSDAQ:475830
Orum Therapeutics Inc
KOSDAQ:475830
Price:
84 300
KRW
2.31%
Market Closed
Market Cap:
₩1.8T
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Popular Picks
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Orum Therapeutics Inc
Other Long-Term Assets
Last
Value
3 Years
3Y
CAGR
5 Years
5Y
CAGR
10 Years
10Y
CAGR
|
See Also
Orum Therapeutics Inc
Other Long-Term Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Other Long-Term Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
O
|
Orum Therapeutics Inc
KOSDAQ:475830
|
Other Long-Term Assets
₩671.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Celltrion Inc
KRX:068270
|
Other Long-Term Assets
₩462.4B
|
CAGR 3-Years
86%
|
CAGR 5-Years
48%
|
CAGR 10-Years
29%
|
|
|
O
|
OliX Pharmaceuticals Inc
KOSDAQ:226950
|
Other Long-Term Assets
₩719.7m
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
N/A
|
|
|
V
|
Voronoi Inc
KOSDAQ:310210
|
Other Long-Term Assets
₩2.5B
|
CAGR 3-Years
57%
|
CAGR 5-Years
25%
|
CAGR 10-Years
N/A
|
|
|
Alteogen Inc
KOSDAQ:196170
|
Other Long-Term Assets
₩53.3B
|
CAGR 3-Years
114%
|
CAGR 5-Years
148%
|
CAGR 10-Years
50%
|
|
|
A
|
ABL Bio Inc
KOSDAQ:298380
|
Other Long-Term Assets
₩873.6m
|
CAGR 3-Years
-20%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
|
No Stocks Found
Orum Therapeutics Inc
Glance View
Orum Therapeutics, Inc. operates as a biotechnology company. The company is headquartered in Daejeon, Daejeon. The company went IPO on 2025-02-14. The firm is principally engaged in the research and development of new biopharmaceuticals for cancer and immune diseases based on its platforms.
Intrinsic Value
800.61
KRW
Overvaluation 99%
O
See Also
What is Orum Therapeutics Inc's Other Long-Term Assets?
Other Long-Term Assets
671.6m
KRW
671.6m
KRW
Based on the financial report for Dec 31, 2024, Orum Therapeutics Inc's Other Long-Term Assets amounts to 671.6m KRW.
What is Orum Therapeutics Inc's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 1Y
-66%
-66%
Over the last year, the Other Long-Term Assets growth was -66%.
